Simplex Trading
FLGT icon

Simplex Trading’s Fulgent Genetics FLGT Stock Holding History

Simplex Trading’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149K Sell
9,400
-43,200
-82% -$938K ﹤0.01% 4636
2025
Q4 		$1.38M Sell
52,600
-112,400
-68% -$2.92M ﹤0.01% 2296
2025
Q3 		$3.73M Sell
165,000
-67,200
-29% -$1.38M ﹤0.01% 1732
2025
Q2 		$4.62M Buy
232,200
+218,000
+1,535% +$4.25M ﹤0.01% 1414
2025
Q1 		$239K Buy
14,200
+11,600
+446% +$198K ﹤0.01% 4133
2024
Q4 		$48K Sell
2,600
-4,300
-62% -$84K ﹤0.01% 5907
2024
Q3 		$149K Buy
6,900
+5,800
+527% +$130K ﹤0.01% 4822
2024
Q2 		$21K Sell
1,100
-4,700
-81% -$98.1K ﹤0.01% 6848
2024
Q1 		$125K Sell
5,800
-300
-5% -$7.45K ﹤0.01% 5352
2023
Q4 		$176K Sell
6,100
-38,600
-86% -$1.03M ﹤0.01% 4796
2023
Q3 		$1.2M Buy
44,700
+40,900
+1,076% +$1.4M ﹤0.01% 2506
2023
Q2 		$140K Buy
3,800
+300
+9% +$10.5K ﹤0.01% 4692
2023
Q1 		$109K Sell
3,500
-10,600
-75% -$341K ﹤0.01% 5058
2022
Q4 		$419K Sell
14,100
-43,000
-75% -$1.54M ﹤0.01% 3355
2022
Q3 		$2.18M Buy
57,100
+39,200
+219% +$1.97M ﹤0.01% 1882
2022
Q2 		$976K Buy
17,900
+3,800
+27% +$209K ﹤0.01% 2652
2022
Q1 		$879K Buy
14,100
+1,300
+10% +$85.6K ﹤0.01% 3068
2021
Q4 		$1.29M Sell
12,800
-23,800
-65% -$2.09M ﹤0.01% 2527
2021
Q3 		$3.2M Hold
36,600
– – ﹤0.01% 1611
2021
Q2 		$3.38M Buy
36,600
+36,104
+7,279% +$2.88M ﹤0.01% 1556
2021
Q1 		$4.79M Buy
496
+253
+104% +$26.1K 0.01% 854
2020
Q4 		$1.27M Buy
243
+232
+2,109% +$9.69K ﹤0.01% 2257
2020
Q3 		$44K Buy
+11
New +$344 ﹤0.01% 5724

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Simplex Trading's FLGT Position: Q3 2025 in Review

Simplex Trading sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 10,821 shares — an estimated $223K sold.

Simplex Trading first reported a position in FLGT in Q3 2020 and held it in 13 quarters. The position peaked at $1.09M in Q4 2020. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Simplex Trading reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 10,821 Fulgent Genetics shares in Q3 2025, an estimated $223K.
  • Simplex Trading first reported a position in Fulgent Genetics in Q3 2020 and held it in 13 quarters.
  • Simplex Trading's Fulgent Genetics position peaked at $1.09M in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.